Phage Display Technique: A Novel Medicinal Approach to Overcome An tibiotic Resistance by Using Peptide-Based Inhibitors Against β-Lactamases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|18|2|90-95

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.18, Iss.2, 2017-03, pp. : 90-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Trends in &bgr;-Lactam Based &bgr;-Lactamases Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 27, 2011-09 ,pp. : 4223-4236

Bentham Science Publishers

Access to resources Recommend Favorite

Is Phage Display Technology on Target for Developing Peptide-Based Cancer Drugs?

By  

Current Drug Discovery Technologies, Vol. 1, Iss. 2, 2004-06 ,pp. : 113-132

Bentham Science Publishers

Access to resources Recommend Favorite

Novel β-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy

By Shukla Girja S.   Krag David N.  

Journal of Drug Targeting, Vol. 18, Iss. 2, 2010-02 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: From Extended Spectrum bgr;-Lactamases to Carbapenemase: The Never Ending Challenge Against Gram-Negative Bacteria)

By  

Current Drug Targets, Vol. 17, Iss. 9, 2016-07 ,pp. : 972-973

Bentham Science Publishers

Access to resources Recommend Favorite

Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases)

By Lynch Joseph P   Clark Nina M   Zhanel George G  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 199-210

Informa Healthcare

Access to resources Recommend Favorite